Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


06.03.2017

1 Acta Neuropathol
5 Alzheimers Dement
1 Am J Geriatr Psychiatry
1 Am J Psychiatry
1 BMC Neurol
1 J Neural Transm (Vienna)
1 Nervenarzt
2 Neurobiol Aging
1 Neurol Clin Pract
1 Neurology
1 PLoS Genet
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neuropathol

  1. DEMING Y, Li Z, Kapoor M, Harari O, et al
    Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.
    Acta Neuropathol. 2017 Feb 28. doi: 10.1007/s00401-017-1685.
    PubMed     Text format     Abstract available


    Alzheimers Dement

  2. MORMINO EC, Papp KV, Rentz DM, Donohue MC, et al
    Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated beta-amyloid.
    Alzheimers Dement. 2017 Feb 27. pii: S1552-5260(17)30044.
    PubMed     Text format     Abstract available

  3. KIN WONG MW, Braidy N, Poljak A, Pickford R, et al
    Dysregulation of lipids in Alzheimer's disease and their role as potential biomarkers.
    Alzheimers Dement. 2017 Feb 24. pii: S1552-5260(17)30012.
    PubMed     Text format     Abstract available

  4. MUKHERJEE S, Russell JC, Carr DT, Burgess JD, et al
    Systems biology approach to late-onset Alzheimer's disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments.
    Alzheimers Dement. 2017 Feb 24. pii: S1552-5260(17)30042.
    PubMed     Text format     Abstract available

  5. JIA J, Gauthier S, Pallotta S, Ji Y, et al
    Consensus-based recommendations for the management of rapid cognitive decline due to Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 23. pii: S1552-5260(17)30011.
    PubMed     Text format     Abstract available

  6. JONSSON L, Lin PJ, Khachaturian AS
    Special topic section on health economics and public policy of Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 20. pii: S1552-5260(17)30085.
    PubMed     Text format    


    Am J Geriatr Psychiatry

  7. MATIAS-GUIU JA, Cabrera-Martin MN, Valles-Salgado M, Perez-Perez A, et al
    Neural Basis of Cognitive Assessment in Alzheimer Disease, Amnestic Mild Cognitive Impairment, and Subjective Memory Complaints.
    Am J Geriatr Psychiatry. 2017 Feb 3. pii: S1064-7481(17)30194.
    PubMed     Text format     Abstract available


    Am J Psychiatry

  8. TAYLOR WD
    Lack of a Role for Alzheimer's Disease Pathology in Late-Life Depression, or Just No Relationship With Amyloid?
    Am J Psychiatry. 2017;174:197-198.
    PubMed     Text format    


    BMC Neurol

  9. TAI SY, Chen CH, Chien CY, Yang YH, et al
    Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: a case control study.
    BMC Neurol. 2017;17:40.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  10. GARN H, Coronel C, Waser M, Caravias G, et al
    Differential diagnosis between patients with probable Alzheimer's disease, Parkinson's disease dementia, or dementia with Lewy bodies and frontotemporal dementia, behavioral variant, using quantitative electroencephalographic features.
    J Neural Transm (Vienna). 2017 Feb 27. doi: 10.1007/s00702-017-1699.
    PubMed     Text format     Abstract available


    Nervenarzt

  11. NAU R, Djukic M, Wappler M
    [Geriatrics - an interdisciplinary challenge].
    Nervenarzt. 2016;87:603-8.
    PubMed     Text format     Abstract available


    Neurobiol Aging

  12. GABELLE A, Jaussent I, Hirtz C, Vialaret J, et al
    Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process.
    Neurobiol Aging. 2017;53:59-66.
    PubMed     Text format     Abstract available

  13. BRENOWITZ WD, Keene CD, Hawes SE, Hubbard RA, et al
    Alzheimer's disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic- and community-based samples.
    Neurobiol Aging. 2017;53:83-92.
    PubMed     Text format     Abstract available


    Neurol Clin Pract

  14. WOODWARD MR, Amrutkar CV, Shah HC, Benedict RH, et al
    Validation of olfactory deficit as a biomarker of Alzheimer disease.
    Neurol Clin Pract. 2017;7:5-14.
    PubMed     Text format     Abstract available


    Neurology

  15. DAY GS, Lim TS, Hassenstab J, Goate AM, et al
    Differentiating cognitive impairment due to corticobasal degeneration and Alzheimer disease.
    Neurology. 2017 Feb 24. pii: 10.1212/WNL.0000000000003770.
    PubMed     Text format     Abstract available


    PLoS Genet

  16. KERR F, Sofola-Adesakin O, Ivanov DK, Gatliff J, et al
    Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.
    PLoS Genet. 2017;13:e1006593.
    PubMed     Text format     Abstract available


    PLoS One

  17. JI H, Wang Y, Liu G, Chang L, et al
    Elevated OPRD1 promoter methylation in Alzheimer's disease patients.
    PLoS One. 2017;12:e0172335.
    PubMed     Text format     Abstract available

  18. KRUSE N, Schlossmacher MG, Schulz-Schaeffer WJ, Vanmechelen E, et al
    A First Tetraplex Assay for the Simultaneous Quantification of Total alpha-Synuclein, Tau, beta-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid.
    PLoS One. 2016;11:e0153564.
    PubMed     Text format     Abstract available

  19. OGAMA N, Sakurai T, Nakai T, Niida S, et al
    Impact of frontal white matter hyperintensity on instrumental activities of daily living in elderly women with Alzheimer disease and amnestic mild cognitive impairment.
    PLoS One. 2017;12:e0172484.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: